Below are the most recent publications written about "Severity of Illness Index" by people in Profiles.
-
Da Cruz RS, Teague HL, Ramos-Benitez MJ, Malavez-Cajigas SJ, Williams T, Miao R, Tian X, Lin G, Busse LW, Khan A, Moskowitz A, Hager DN, Rice TW, Ginde AA, Iovine NM, Chen P, Safdar B, Gibbs KW, Javaheri A, de Wit M, Harkins M, Hudock K, Merck LH, Barksdale A, Sturek JM, Schrager H, Shapiro NI, Lanspa M, Harris E, Sellers S, Goodwin AJ, Tidswell MA, Filbin MR, Shotwell MS, Semler MW, Self WH, Collins SP, Strich JR. Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19. Crit Care Explor. 2026 Jul 01; 8(7):e1405.
-
Labaki WW, Ram S, Namvar A, Bell AJ, Hoff BA, Kazerooni EA, Galban S, Martinez FJ, Hatt CR, Murray S, Mirkes EM, Gorban AN, Zinovyev A, Han MK, Galban CJ. Elastic parametric response mapping: quantitative CT scoring for local COPD severity. Thorax. 2026 Jun 15; 81(7):654-663.
-
Nishimi K, Linnstaedt SD, Neylan TC, McKibben LA, Albertorio-S?ez LM, Zhao Y, House SL, Beaudoin FL, An X, Stevens JS, Clifford GD, Jovanovic T, Germine LT, Rauch SL, Haran JP, Storrow AB, Musey PI, Hendry PL, Sheikh S, Punches BE, Swor RA, Pascual JL, Seamon MJ, Datner EM, Pearson C, Peak DA, Merchant RC, Domeier RM, Rathlev NK, O'Neil BJ, Sergot P, Sanchez LD, Bruce SE, Harte SE, Kessler RC, Koenen KC, Ressler KJ, McLean SA, O'Donovan A. Inflammatory markers in the emergency department and PTSD symptoms in the AURORA Study: A longitudinal cohort study. Psychol Med. 2026 May 08; 56:e123.
-
Eleftheriadou V, Desai S, Bae JM, Taylor S, Meurant JM, Abdallah M, Ju HJ, Benzekri L, Wolkerstorfer A, B?hm M, Xiang LF, Rush E, Hamzavi IH, Passeron T, Lim H, Harris JE, Parsad D, Huggins R, Schneider A, Kolios A, Rosmarin D, Mohammad TF, Esmat SM, Jones J, Retzer A, Seneschal J, Gkini MA, Ahmed A, Thompson A, Pandya AG, Cruz Rivera S, Kpenou FC, Ezzedine K. Definition of Severity and Relapse for Vitiligo: An International Consensus Statement. JAMA Dermatol. 2026 May 01; 162(5):515-524.
-
Leaf DE, Monson AE, Dias JA, Marcos LA, Wu U, Rossi M, Ng JH, Patell R, Hundert J, El Khoury MY, Higgs J, Smith RP, Ramsaroop V, Green A, Abdul Azim A, Weisenberg S, Kirkman LA, Ingram D, Hsu CM, Dieckhaus K, Hyson P, Burger Z, Chengsupanimit T, Stalmack T, Aber R, Golden M, Koshy M, Wright K, Cortezzo G, McLeod G, Wenzel-Rideout R, Baigorri JJ, Bagchi A, Jaser A, Socorro Matos G, Sanchez-Almanzar D, Hoge ST, Shenoy T, Krishnamurthy S, Kaunfer SA, Blau JA, Woolley A, Zamor R, Maczaj B, Kenison D, Totten A, Bateman V, Mohsin S, Lee ES, Garner J, Rath P, Wu Q, Guermazi D, London A, Arvanitis P, Yune PS, Abdullah M, Kim A, Roy J, George R, Kashfi S, Hong S, Upadrista P, Hirsch JS, Bulteel A, Sharma R, Guo T, Garcia D, Shaefi S, Yeb J, Williams G, Verma E, Gouda N, Rosenthal HR, Chan A, Zainah H, Heithaus S, Saldivar MA, Wood E, DiPalazzo J, Elias S, McAuliffe M, Abbas R, Orenstein A, Tidswell MA, Galiano P, Spencer S, Srinivasan S, Xu J, Alla S, Alidoost L, Jacobson E, Menghani SV, Kannabran P, Ogunribido DB, Ssentongo P, Powell D, Meyer L, Prabhune K, Griffiths B, Gonzalez Aponte D, Dixon G, Vannier E, Roberts SC, Farmakiotis D, Krause PJ. Red Blood Cell Exchange Transfusion for Severe Babesiosis. JAMA Intern Med. 2026 May 01; 186(5):597-607.
-
Ma KC, Surie D, Lauring AS, Martin ET, Leis AM, Papalambros L, Gaglani M, Columbus C, Gottlieb RL, Ghamande S, Peltan ID, Brown SM, Ginde AA, Mohr NM, Gibbs KW, Hager DN, Saeed S, Prekker ME, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Khan A, Hough CL, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Kwon JH, Parikh B, Exline MC, Vaughn IA, Ramesh M, Safdar B, Mosier J, Harris ES, Shapiro NI, Felzer J, Zhu Y, Grijalva CG, Halasa N, Chappell JD, Womack KN, Rhoads JP, Baughman A, Swan SA, Johnson CA, Rice TW, Casey JD, Blair PW, Han JH, Ellington S, Lewis NM, Thornburg N, Paden CR, Atherton LJ, Self WH, Dawood FS, DeCuir J. Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024. Clin Infect Dis. 2026 Mar 17; 82(3):e595-e603.
-
Eerdekens R, Johnson NP, Adrichem R, van Mieghem NM, Eftekhari A, Kakouros N, Demandt JPA, Farissi ME, Vervaat FE, Houthuizen P, Felix SEA, Bouwmeester S, van 't Veer M, Johnson DT, Gould KL, Tonino PAL. Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis. EuroIntervention. 2026 Mar 16; 22(6):e347-e357.
-
Carbone E, Zingaropoli MA, Perrone F, Talarico G, Pasculli P, Minni A, Petrella C, Barbato C, Piscopo P. Profile of Tau-Associated Selected MicroRNAs in Hospitalized COVID-19 Patients: An Exploratory Single-Center Study. Cells. 2026 Mar 12; 15(6).
-
G?n?reux P, Reynolds MR, Kelley MA, Thompson C, Baron SJ. Cost-Effectiveness of TAVR Compared With Clinical Surveillance in Patients with Asymptomatic Severe Aortic Stenosis in the United States. Value Health. 2026 Jul; 29(7):1171-1179.
-
Ihdayhid AR, Sellers SL, Polsani V, Fairbairn T, Khoo J, Fitzgibbons TP, Corrigan F, Ko B, Gooley R, Vucic E, Liu S, Coughlan F, Yong G, Shetty S, Chatfield A, Akodad M, Mohammadi A, Raju V, Lewin S, Blanke P, Kakouros N, Sathananthan J, Webb J, Wood D, Leipsic J. Feasibility and utility of anatomical and physiological evaluation of coronary artery disease with cardiac CT in severe aortic stenosis (FUTURE-AS registry). J Cardiovasc Comput Tomogr. 2026 Mar-Apr; 20(2):148-156.